Results 111 to 120 of about 28,958 (244)

Primary cardiovascular preventive effect of thiazolidinedione in adults with type 2 diabetes: A nationwide cohort study in Korea

Journal of Diabetes Investigation, Volume 17, Issue 8, Page 1367-1378, August 2026.
Among Korean adults with type 2 diabetes and no prior cardiovascular disease, thiazolidinedione use was associated with a lower risk of the primary composite outcome of stroke, myocardial infarction, hospitalization for heart failure, and all‐cause mortality compared to dipeptidyl peptidase‐4 inhibitor use. ABSTRACT Background Thiazolidinediones (TZDs)
Yun Young Choi, Jimin Jeon, Minyoul Baik, Joonsang Yoo, Jinkwon Kim   +4 more
wiley   +1 more source

Dapagliflozin does not impair microvascular hemorheology in type 2 diabetes mellitus: A multicenter randomized controlled trial (D‐PATH study)

Journal of Diabetes Investigation, Volume 17, Issue 8, Page 1322-1334, August 2026.
Graphical abstract illustrating the study design, physiological rationale, and key findings of the D‐PATH trial. Dapagliflozin, an SGLT2 inhibitor, lowers HbA1c and body weight while increasing hematocrit and erythropoietin levels. Although an elevated hematocrit could theoretically increase blood viscosity and impair microcirculatory flow, ex vivo ...
Yuki Nakatani, Nobuyuki Banba, Shoya Ono, Tomoki Turumi, Megumi Hoshiai, Takushi Sugiyama, Takashi Tomoe, Hajime Tamiya, Naoyuki Otani, Hiroyuki Sugimura, Hidekazu Ikemiyagi, Yusuke Ohya, Koji Yokokawa, Shinichiro Ueda, Yoshimasa Aso, Yasuhiro Maejima, Takanori Yasu   +16 more
wiley   +1 more source

Evaluation of Intralesional Triamcinolone Acetonide and Platelet‐Rich Plasma Therapy in Patients With Mild Patch‐Type Alopecia Areata

Journal of Cosmetic Dermatology, Volume 25, Issue 8, August 2026.
ABSTRACT Introduction Alopecia areata is a long‐term autoimmune disease that causes hair loss in approximately 2% of people but does not result in permanent scarring. Intralesional corticosteroid treatment provides effective results; however, long‐term use may lead to skin atrophy and telangiectasia.
Ramazan Ülker, İlknur Yorğun Özdemir, Hatice Uce Özkol   +2 more
wiley   +1 more source

Dabigatran versus warfarin in patients with atrial fibrillation.

New England Journal of Medicine, 2009
S. Connolly, M. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, J. Pogue, P. Reilly, E. Themeles, Jeanne Varrone, Susan Wang, M. Alings, D. Xavier, Jun Zhu, R. Diaz, B. Lewis, H. Darius, H. Diener, C. Joyner, L. Wallentin   +19 more
semanticscholar   +1 more source

Direct oral anticoagulants and warfarin in atrial fibrillation patients with cancer by anticoagulation quality

Cancer, Volume 132, Issue 14, 15 July 2026.
Patients with atrial fibrillation (AF) and cancer treated with direct oral anticoagulants (DOACs) had a lower risk of all‐cause mortality, cardiovascular events (CVEs), but not bleeding events, compared to patients treated with vitamin K antagonists (VKAs) with low anticoagulation quality.
Danilo Menichelli, Vito Maria Daniele Cormaci, Gianluca Gazzaniga, Irma Bisceglia, Massimiliano Camilli, Daniela Poli, Emilia Antonucci, Roberto Pola, Paolo Santini, Pasquale Pignatelli, Daniele Pastori, on behalf of the START2 Registry Investigators   +11 more
wiley   +1 more source

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

New England Journal of Medicine, 2017
C. Cannon, Deepak L. Bhatt, J. Oldgren, G. Lip, S. Ellis, Takeshi Kimura, M. Maeng, B. Merkely, U. Zeymer, S. Gropper, M. Nordaby, E. Kleine, Ruth Harper, Jenny Manassie, J. Januzzi, J. T. ten Berg, G. Steg, S. Hohnloser   +17 more
semanticscholar   +1 more source

Dabigatran versus warfarin in the treatment of acute venous thromboembolism.

New England Journal of Medicine, 2009
S. Schulman, C. Kearon, A. Kakkar, P. Mismetti, S. Schellong, H. Eriksson, David Baanstra, J. Schnee, S. Goldhaber   +8 more
semanticscholar   +1 more source

Dabigatran (October 2011)

Cleveland Clinic Journal of Medicine, 2012
Readers comment on the oral anticoagulant dabigatran (October 2011), and screening for cervical cancer (November 2011).
openaire   +2 more sources

Dabigatran accumulation in acute kidney injury: is more better than less to prevent bleeding? A case report

International Journal of Emergency Medicine
Dabigatran is an oral anticoagulant that is mainly renally excreted. Despite its efficacy in preventing thromboembolic events, concerns arise regarding bleeding complications in patients with acute kidney injury. Idarucizumab is its specific antidote and
Rafik Matbouli, Olivier Pantet, Julien Castioni, Nima Vakilzadeh, Lorenzo Alberio, Olivier Hugli   +5 more
doaj   +1 more source

Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation

New England Journal of Medicine, 2017
H. Calkins, S. Willems, E. Gerstenfeld, A. Verma, R. Schilling, S. Hohnloser, K. Okumura, H. Serota, M. Nordaby, K. Guiver, B. Biss, M. Brouwer, M. Grimaldi   +12 more
semanticscholar   +2 more sources